EVANS SYNDROME
Clinical trials for EVANS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new EVANS SYNDROME trials appear
Sign up with your email to follow new studies for EVANS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody drug offers hope for stubborn blood disorders
Disease control Recruiting nowThis study tests a new drug called CM336 in people with autoimmune cytopenia, a condition where the immune system attacks blood cells. The drug aims to control the disease by targeting certain immune cells. About 158 adults with relapsed or refractory forms of immune thrombocytop…
Matched conditions: EVANS SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Keymed Biosciences Co.Ltd • Aim: Disease control
Last updated May 26, 2026 08:58 UTC
-
Engineered immune cells take on autoimmune blood diseases
Disease control Recruiting nowThis early-stage study tests a new treatment called RD06-05, a universal CAR-T cell therapy, in 27 adults with autoimmune blood diseases like immune thrombocytopenia (ITP), autoimmune hemolytic anemia (AIHA), or Evans syndrome. The therapy targets specific immune cells to reduce …
Matched conditions: EVANS SYNDROME
Phase: EARLY_PHASE1 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated May 22, 2026 13:50 UTC